| LEGAX | VIGRX | LEGAX / VIGRX | |
| Total Expense Ratio | 0.97 | 0.17 | 571% |
| Annual Report Gross Expense Ratio | 0.97 | 0.17 | 571% |
| Fund Existence | 27 years | 33 years | - |
| Gain YTD | -2.726 | -2.997 | 91% |
| Front Load | 6% | N/A | - |
| Min. Initial Investment | 2000 | 3000 | 67% |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 6.24B | 352B | 2% |
| Annual Yield % from dividends | 0.00 | 0.30 | - |
| Returns for 1 year | 2.37 | 14.30 | 17% |
| Returns for 3 years | 60.62 | 94.65 | 64% |
| Returns for 5 years | 35.43 | 79.50 | 45% |
| Returns for 10 years | 157.12 | 395.65 | 40% |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| TINCX | 3.10 | 0.03 | +0.98% |
| Templeton Global Dynamic Income A1 | |||
| JPVZX | 21.03 | 0.18 | +0.86% |
| JPMorgan Developed International ValueR2 | |||
| CGVFX | 29.04 | -0.26 | -0.89% |
| American Funds Global Insight 529-F-1 | |||
| ISFIX | 18.48 | -0.23 | -1.23% |
| VY® Columbia Contrarian Core I | |||
| BIVIX | 16.69 | -0.51 | -2.97% |
| Invenomic Institutional | |||